152 related articles for article (PubMed ID: 18289622)
21. 17-Beta-estradiol inhibits transforming growth factor-beta signaling and function in breast cancer cells via activation of extracellular signal-regulated kinase through the G protein-coupled receptor 30.
Kleuser B; Malek D; Gust R; Pertz HH; Potteck H
Mol Pharmacol; 2008 Dec; 74(6):1533-43. PubMed ID: 18768737
[TBL] [Abstract][Full Text] [Related]
22. The membrane estrogen receptor GPR30 mediates cadmium-induced proliferation of breast cancer cells.
Yu X; Filardo EJ; Shaikh ZA
Toxicol Appl Pharmacol; 2010 May; 245(1):83-90. PubMed ID: 20153348
[TBL] [Abstract][Full Text] [Related]
23. GPER, IGF-IR, and EGFR transduction signaling are involved in stimulatory effects of zinc in breast cancer cells and cancer-associated fibroblasts.
Pisano A; Santolla MF; De Francesco EM; De Marco P; Rigiracciolo DC; Perri MG; Vivacqua A; Abonante S; Cappello AR; Dolce V; Belfiore A; Maggiolini M; Lappano R
Mol Carcinog; 2017 Feb; 56(2):580-593. PubMed ID: 27341075
[TBL] [Abstract][Full Text] [Related]
24. GPR30: A G protein-coupled receptor for estrogen.
Prossnitz ER; Arterburn JB; Sklar LA
Mol Cell Endocrinol; 2007 Feb; 265-266():138-42. PubMed ID: 17222505
[TBL] [Abstract][Full Text] [Related]
25. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
[TBL] [Abstract][Full Text] [Related]
26. Calycosin inhibits the in vitro and in vivo growth of breast cancer cells through WDR7-7-GPR30 Signaling.
Tian J; Wang Y; Zhang X; Ren Q; Li R; Huang Y; Lu H; Chen J
J Exp Clin Cancer Res; 2017 Nov; 36(1):153. PubMed ID: 29096683
[TBL] [Abstract][Full Text] [Related]
27. The activation of G protein-coupled estrogen receptor induces relaxation via cAMP as well as potentiates contraction via EGFR transactivation in porcine coronary arteries.
Yu X; Stallone JN; Heaps CL; Han G
PLoS One; 2018; 13(1):e0191418. PubMed ID: 29360846
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of GPR30 by estriol prevents growth stimulation of triple-negative breast cancer cells by 17β-estradiol.
Girgert R; Emons G; Gründker C
BMC Cancer; 2014 Dec; 14():935. PubMed ID: 25496649
[TBL] [Abstract][Full Text] [Related]
29. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.
Schlange T; Matsuda Y; Lienhard S; Huber A; Hynes NE
Breast Cancer Res; 2007; 9(5):R63. PubMed ID: 17897439
[TBL] [Abstract][Full Text] [Related]
30. GPCR-induced migration of breast carcinoma cells depends on both EGFR signal transactivation and EGFR-independent pathways.
Hart S; Fischer OM; Prenzel N; Zwick-Wallasch E; Schneider M; Hennighausen L; Ullrich A
Biol Chem; 2005 Sep; 386(9):845-55. PubMed ID: 16164409
[TBL] [Abstract][Full Text] [Related]
31. GPER mediates the angiocrine actions induced by IGF1 through the HIF-1α/VEGF pathway in the breast tumor microenvironment.
De Francesco EM; Sims AH; Maggiolini M; Sotgia F; Lisanti MP; Clarke RB
Breast Cancer Res; 2017 Dec; 19(1):129. PubMed ID: 29212519
[TBL] [Abstract][Full Text] [Related]
32. G-protein-coupled estrogen receptor GPR30 and tamoxifen resistance in breast cancer.
Ignatov A; Ignatov T; Weissenborn C; Eggemann H; Bischoff J; Semczuk A; Roessner A; Costa SD; Kalinski T
Breast Cancer Res Treat; 2011 Jul; 128(2):457-66. PubMed ID: 21607586
[TBL] [Abstract][Full Text] [Related]
33. Nuclear alternate estrogen receptor GPR30 mediates 17beta-estradiol-induced gene expression and migration in breast cancer-associated fibroblasts.
Madeo A; Maggiolini M
Cancer Res; 2010 Jul; 70(14):6036-46. PubMed ID: 20551055
[TBL] [Abstract][Full Text] [Related]
34. Epidermal growth factor induces WISP-2/CCN5 expression in estrogen receptor-alpha-positive breast tumor cells through multiple molecular cross-talks.
Banerjee S; Sengupta K; Saxena NK; Dhar K; Banerjee SK
Mol Cancer Res; 2005 Mar; 3(3):151-62. PubMed ID: 15798095
[TBL] [Abstract][Full Text] [Related]
35. GPER mediates activation of HIF1α/VEGF signaling by estrogens.
De Francesco EM; Pellegrino M; Santolla MF; Lappano R; Ricchio E; Abonante S; Maggiolini M
Cancer Res; 2014 Aug; 74(15):4053-64. PubMed ID: 24894716
[TBL] [Abstract][Full Text] [Related]
36. Epidermal growth factor receptor and tyrosine phosphorylation of estrogen receptor.
Márquez DC; Lee J; Lin T; Pietras RJ
Endocrine; 2001 Nov; 16(2):73-81. PubMed ID: 11887937
[TBL] [Abstract][Full Text] [Related]
37. GPR30 expression and function in breast cancer cells are induced through a cis‑acting element targeted by ETS factors.
Segura-Bautista D; Olivares A; Casas-González P; Bonilla E; Salazar Z; Pérez-Solis MA
Oncol Rep; 2020 May; 43(5):1669-1682. PubMed ID: 32323852
[TBL] [Abstract][Full Text] [Related]
38. Mechanisms of estrogen signaling and gene expression via GPR30.
Prossnitz ER; Maggiolini M
Mol Cell Endocrinol; 2009 Sep; 308(1-2):32-8. PubMed ID: 19464786
[TBL] [Abstract][Full Text] [Related]
39. A transmembrane intracellular estrogen receptor mediates rapid cell signaling.
Revankar CM; Cimino DF; Sklar LA; Arterburn JB; Prossnitz ER
Science; 2005 Mar; 307(5715):1625-30. PubMed ID: 15705806
[TBL] [Abstract][Full Text] [Related]
40. Nuclear estrogen receptor-mediated Notch signaling and GPR30-mediated PI3K/AKT signaling in the regulation of endometrial cancer cell proliferation.
Wei Y; Zhang Z; Liao H; Wu L; Wu X; Zhou D; Xi X; Zhu Y; Feng Y
Oncol Rep; 2012 Feb; 27(2):504-10. PubMed ID: 22075757
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]